Bruce K. Dallas
Lawyers
Filters
TTX Company $300 Million Medium-Term Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $300 million aggregate principal amount of its 2.250%…
Ardelyx, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with an $86.2 million SEC-registered follow-on common stock offering of 8,625,000 shares of common stock for Ardelyx, Inc…
Adamas Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $66.1 million SEC-registered common stock offering of 2,875,000 shares of common stock of Adamas Pharmaceuticals, Inc…
Inphi Corporation $230 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Inphi Corporation of $230 million aggregate principal amount of its 1.125%…
Davis Polk Advises Roper Technologies on Its $900 Million Notes Offering
Davis Polk advised Roper Technologies, Inc. on its SEC-registered offering of $600 million aggregate principal amount of 3.000% senior notes due 2020 and $300 million aggregate principal…
Global Blood Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $138 million initial public offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock…
Aimmune Therapeutics, Inc. $183.9 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $183.9 million initial public offering of Aimmune Technologies, Inc. Aimmune Therapeutics sold 11,499,999 shares of its…
Atara Biotherapeutics, Inc. $207 Million Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $207 million SEC-registered follow-on offering of common stock of Atara Biotherapeutics, Inc. The common stock…
TTX Company $300 Million Medium-Term Note Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $300 million aggregate principal amount of its 2.6%…
Davis Polk Advises Texas Instruments on $500 Million Notes Offering
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $500 million aggregate principal amount of 1.750% notes due 2020.
Texas Instruments…